Cynthia Evans

5.7k total citations · 2 hit papers
40 papers, 1.6k citations indexed

About

Cynthia Evans is a scholar working on Physiology, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Cynthia Evans has authored 40 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 10 papers in Psychiatry and Mental health and 7 papers in Pharmacology. Recurrent topics in Cynthia Evans's work include Alzheimer's disease research and treatments (10 papers), Dementia and Cognitive Impairment Research (7 papers) and Autoimmune Bullous Skin Diseases (4 papers). Cynthia Evans is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Dementia and Cognitive Impairment Research (7 papers) and Autoimmune Bullous Skin Diseases (4 papers). Cynthia Evans collaborates with scholars based in United States, United Kingdom and Singapore. Cynthia Evans's co-authors include John R. Sims, Sergey Shcherbinin, Mark A. Mintun, Scott W. Andersen, Albert Lo, Paul Ardayfio, JonDavid Sparks, Stephen Salloway, Mirosław Bryś and Liana G. Apostolova and has published in prestigious journals such as New England Journal of Medicine, Neurology and The Journal of Urology.

In The Last Decade

Cynthia Evans

38 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Donanemab in Early Alzheimer’s Disease

2021 969 citations Mark A. Mintun, Albert Lo et al. New England Journal of Medicine profile →
Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease

2025 29 citations Jennifer A. Zimmer, Paul Ardayfio et al. JAMA Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cynthia Evans United States	15	895	485	318	279	218	40	1.6k
Yuki Mukai Japan	12	789 0.9×	294 0.6×	387 1.2×	252 0.9×	163 0.7×	42	1.3k
Rawan Tarawneh United States	16	664 0.7×	386 0.8×	117 0.4×	317 1.1×	247 1.1×	29	1.5k
Masayoshi Shibata Japan	13	884 1.0×	119 0.2×	155 0.5×	396 1.4×	395 1.8×	44	2.0k
Katy Chalmers United Kingdom	19	647 0.7×	174 0.4×	137 0.4×	597 2.1×	207 0.9×	35	1.5k
Richard Batrla Switzerland	15	1.2k 1.3×	906 1.9×	91 0.3×	494 1.8×	339 1.6×	24	2.4k
Yoko Okamoto Japan	26	529 0.6×	189 0.4×	190 0.6×	553 2.0×	433 2.0×	55	1.9k
Michael T. Falduto United States	21	865 1.0×	110 0.2×	206 0.6×	764 2.7×	142 0.7×	35	1.9k
Patrice Verpillat France	24	621 0.7×	323 0.7×	279 0.9×	415 1.5×	245 1.1×	74	2.1k
Edward Tobinick United States	22	594 0.7×	72 0.1×	159 0.5×	420 1.5×	588 2.7×	30	1.7k

Countries citing papers authored by Cynthia Evans

Since Specialization

Citations

This map shows the geographic impact of Cynthia Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cynthia Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cynthia Evans more than expected).

Fields of papers citing papers by Cynthia Evans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cynthia Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cynthia Evans. The network helps show where Cynthia Evans may publish in the future.

Co-authorship network of co-authors of Cynthia Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Cynthia Evans. A scholar is included among the top collaborators of Cynthia Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cynthia Evans. Cynthia Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zimmer, Jennifer A., John R. Sims, Cynthia Evans, et al.. (2025). Donanemab in early symptomatic Alzheimer’s disease: results from the TRAILBLAZER-ALZ 2 long-term extension. The Journal of Prevention of Alzheimer s Disease. 13(2). 100446–100446.

Zimmer, Jennifer A., Paul Ardayfio, Hong Wang, et al.. (2025). Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease. JAMA Neurology. 82(5). 461–461. 29 indexed citations breakdown →

Greenberg, Steven M., Ming‐Chi Lu, Alessandro Biffi, et al.. (2024). ARIA Insights from the Donanemab Trials (P1-9.001). Neurology. 102(7_supplement_1). 3339–3339. 5 indexed citations

Mintun, Mark A., Craig Ritchie, Paul R. Solomon, et al.. (2023). Donanemab in Early Symptomatic Alzheimer’s Disease: Efficacy and Safety in TRAILBLAZER‐ALZ 2, a Phase 3 Randomized Clinical Trial. Alzheimer s & Dementia. 19(S24). 6 indexed citations

Shcherbinin, Sergey, Ivelina Gueorguieva, Cynthia Evans, et al.. (2023). Amyloid re‐accumulation after donanemab treatment: summary from 3 interventional trials. Alzheimer s & Dementia. 19(S14). 3 indexed citations

Evans, Cynthia, JonDavid Sparks, Scott W. Andersen, et al.. (2023). APOE ε4's impact on response to amyloid therapies in early symptomatic Alzheimer's disease: Analyses from multiple clinical trials. Alzheimer s & Dementia. 19(12). 5407–5417. 8 indexed citations

Evans, Cynthia, et al.. (2023). Elucidating the Varying Impact of Necrotic Enteritis Using Performance and Health Indicators in Broiler Infection Models. Avian Diseases. 67(4). 326–339. 3 indexed citations

Shcherbinin, Sergey, Amanda Sheffield Morris, Ixavier A. Higgins, et al.. (2023). Tau as a diagnostic instrument in clinical trials to predict amyloid in Alzheimer's disease. Alzheimer s & Dementia Translational Research & Clinical Interventions. 9(3). e12415–e12415. 10 indexed citations

Shcherbinin, Sergey, Cynthia Evans, Ming‐Chi Lu, et al.. (2022). Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes. JAMA Neurology. 79(10). 1015–1015. 117 indexed citations

10.

Mintun, Mark A., Albert Lo, Cynthia Evans, et al.. (2021). Donanemab in Early Alzheimer’s Disease. New England Journal of Medicine. 384(18). 1691–1704. 969 indexed citations breakdown →

11.

Lo, Albert, Cynthia Evans, Michele Mancini, et al.. (2021). Phase II (NAVIGATE-AD study) Results of LY3202626 Effects on Patients with Mild Alzheimer’s Disease Dementia. Journal of Alzheimer s Disease Reports. 5(1). 321–336. 22 indexed citations

12.

Lowe, Stephen L., Cynthia Evans, Sergey Shcherbinin, et al.. (2021). Donanemab (LY3002813) Phase 1b Study in Alzheimer's Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging. The Journal of Prevention of Alzheimer s Disease. 8(4). 414–424. 74 indexed citations

13.

Quick, Allison, Catherine O. Hudson, Andrew F. Hundley, et al.. (2019). Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors. Supportive Care in Cancer. 28(8). 3669–3677. 33 indexed citations

14.

Langtry, J.A.A., et al.. (2005). Pyoderma gangrenosum associated with hidradenitis suppurativa. Clinical and Experimental Dermatology. 30(6). 669–671. 42 indexed citations

15.

Gryn, Jeffrey, Zella R. Zeigler, Richard K. Shadduck, et al.. (2002). Treatment of myelodysplastic syndromes with 5-azacytidine. Leukemia Research. 26(10). 893–897. 40 indexed citations

16.

Douglas, W.S., et al.. (1994). Contact dermatitis from the old formula E45 cream. Contact Dermatitis. 30(3). 159–161. 6 indexed citations

17.

Morton, C.A., Cynthia Evans, & W.S. Douglas. (1993). Allergic contact dermatitis following subconjunctival injection of framycetin. Contact Dermatitis. 29(1). 42–43. 4 indexed citations

18.

Franco, Kathleen, et al.. (1991). Dopaminergic Activity and Idiopathic Edema. Psychiatric Services. 42(3). 309–310. 15 indexed citations

19.

Evans, Cynthia, R S Pereira, C-T. Yuen, & C.A. HOLDEN. (1988). Anti-collagen antibodies in granuloma annulare and necrobiosis lipoidica. Clinical and Experimental Dermatology. 13(4). 252–254. 10 indexed citations

20.

Evans, Cynthia, et al.. (1960). A Method for Assessing the Stinging Caused by Eyedrops. Ophthalmologica. 139(5). 431–438. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact